These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6332144)

  • 1. Inhibition of human IL 2 production by MDP and derivatives.
    Leclerc C; Morin A; Deriaud E; Chedid L
    J Immunol; 1984 Oct; 133(4):1996-2000. PubMed ID: 6332144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
    Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
    J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
    Bahr GM; Modabber FZ; Morin A; Terrier M; Eyquem A; Chedid L
    Clin Exp Immunol; 1984 Jul; 57(1):178-86. PubMed ID: 6744667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
    Santoli D; Zurier RB
    J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target cells for immunomodulatory action of muramyl dipeptide.
    Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
    Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
    Leclerc C; Bourgeois E; Chedid L
    Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
    Walker C; Kristensen F; Bettens F; deWeck AL
    J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
    Brown SL; Van Epps DE
    J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of interleukin 2 in multiple myeloma.
    Commes T; Klein B; Jourdan M; Bataille R
    Clin Exp Immunol; 1986 Mar; 63(3):533-40. PubMed ID: 3486731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
    Todate A; Suda T; Kuwata H; Chida K; Nakamura H
    J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of human endothelial cells by synthetic muramyl peptides: production of colony-stimulating activity (CSA).
    Galelli A; Dosne AM; Morin A; Dubor F; Chedid L
    Exp Hematol; 1985 Dec; 13(11):1157-63. PubMed ID: 3877645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of and response to interleukin-2 by cultured T cells: effects of lithium chloride and other putative modulators.
    Kishter S; Hoffman FA; Pizzo PA
    J Biol Response Mod; 1985 Apr; 4(2):185-94. PubMed ID: 2987421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA; Jelinek DF; Lipsky PE
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genomic immunosuppressive actions of progesterone inhibits PHA-induced alkalinization and activation in T cells.
    Chien EJ; Chang CP; Lee WF; Su TH; Wu CH
    J Cell Biochem; 2006 Sep; 99(1):292-304. PubMed ID: 16619256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
    Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
    J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.